4.7 Article

In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

In Vitro Activity of Nitroxoline in Antifungal-Resistant Candida Species Isolated from the Urinary Tract

Frieder Fuchs et al.

Summary: The antifungal activity of nitroxoline was assessed in yeasts from urinary tract infections, and the results showed that nitroxoline is highly effective against various Candida species, regardless of resistance to other antifungal agents.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Infectious Diseases

In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract

Frieder Fuchs et al.

Summary: This study investigated the in vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii. The results showed that nitroxoline exhibited excellent activity against a collection of carbapenem-resistant Acinetobacter baumannii isolates. This suggests that nitroxoline could be a promising drug for the treatment of lower urinary tract infections caused by this bacterium.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Infectious Diseases

Antifungal activity of nitroxoline against Candida auris isolates

Frieder Fuchs et al.

Summary: Nitroxoline exhibits excellent in vitro activity against C. auris isolates, especially those belonging to clade I. The MIC range of nitroxoline is 0.125-1 mg/L.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli

Fabiola Puertolas-Balint et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Review Infectious Diseases

Novel Treatments againstMycobacterium tuberculosisBased on Drug Repurposing

Alvaro Mourenza et al.

ANTIBIOTICS-BASEL (2020)

Article Chemistry, Medicinal

8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis

Joshua O. Odingo et al.

DRUG DEVELOPMENT RESEARCH (2019)

Article Microbiology

Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing

Kingsley King-Gee Tam et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2019)

Article Immunology

Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017

Yu Pang et al.

EMERGING INFECTIOUS DISEASES (2019)

Review Infectious Diseases

Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline

Rixt A. Wijma et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Article Nanoscience & Nanotechnology

Albumin-Stabilized Metal-Organic Nanoparticles for Effective Delivery of Metal Complex Anticancer Drugs

Ding Hu et al.

ACS APPLIED MATERIALS & INTERFACES (2018)

Article Infectious Diseases

Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria

Yasmeen Abouelhassan et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)

Article Microbiology

8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis

Santosh Shah et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Letter Microbiology

In Vitro Activity of Nitroxoline against Escherichia coli Urine Isolates from Outpatient Departments in Germany

Michael Kresken et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Infectious Diseases

In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG

B Murugasu-Oei et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)